Novel protocol for prevention from hepatitis B reactivation following living‐donor liver transplantation

2024-9-14

Hepatic Mac2‐BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction‐associated steatotic liver disease

2024-9-10

Issue Information

2024-9-1

Elevated nuclear expression of ZHX1 correlates with poor prognosis in hepatocellular carcinoma (HCC): Comparison of nuclear and cytoplasmic distribution of the ZHX family in HCC cells

2024-8-29

Efficacy of steroid therapy for improving native liver survival after pediatric acute liver failure with immune activation

2024-8-21

Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection

2024-8-20

Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up

2024-8-19

Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma

2024-8-17

What can we create by adding robotic assistance to conventional laparoscopic liver resection?

2024-8-12

Reply to Letter to the Editor: Regarding the “Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy”

2024-8-12

Interleukin‐33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosis

2024-8-12

Genetic alteration of <i>SLCO1B3</i> defines constitutional indocyanine green excretory defect in patients who underwent hepatectomy

2024-8-12

Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period

2024-8-7

Issue Information

2024-8-1

High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma

2024-7-29

Improved survival outcome of curative liver resection for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma in the era of tyrosine kinase inhibitors

2024-7-26

Molecular biological role of epithelial splicing regulatory protein 1 in intrahepatic cholangiocarcinoma

2024-7-22

What we know and need to know about Fontan‐associated liver disease

2024-7-16

Evaluation of the associations of interlukin‐7 genetic variants with toxicity and efficacy of immune checkpoint inhibitors: A replication study of a Japanese population, based on the findings of a European genome‐wide association study

2024-7-11

Importance of gamma‐glutamyl transferase elevation in patients with Fontan‐associated liver disease

2024-7-10

Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study

2024-7-2

Issue Information

2024-7-1

Nutritional management for acute liver failure

2024-7-1

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis

2024-6-29

Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: A treatment dilemma–Authors' reply

2024-6-29

Changes in alanine aminotransferase and body composition and metabolic factors among individuals receiving medical health checkups

2024-6-25

Regarding the “Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy”

2024-6-22

Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: A treatment dilemma

2024-6-22

Combination of risk alleles of <i>PNPLA3</i>, <i>TM6SF2</i>, and <i>HSD17B13</i> of donors can predict recurrence of steatotic liver disease after liver transplantation

2024-6-20

Diagnostic guide for immune checkpoint inhibitor‐induced liver injury

2024-6-17

Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication

2024-6-17

Grip strength complements performance status in assessing general condition in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab

2024-6-15

Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan

2024-6-15

Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection

2024-6-14

Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure

2024-6-14

Novel mutation of transferrin receptor 2 causing hereditary hemochromatosis type 3 in a Japanese patient

2024-6-8

Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis

2024-6-5

Issue Information

2024-6-1

Treatment of liver cirrhosis in the era of steatotic liver disease

2024-5-28

Influence of dispersion slope on the diagnosis of liver fibrosis by the shear wave in metabolic dysfunction‐associated steatotic liver disease

2024-5-28

Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B

2024-5-28

Current status and future perspectives of robotic liver surgery

2024-5-27

Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations

2024-5-27

Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis

2024-5-23

Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy

2024-5-21

A nation‐wide medical record database study: Value of hepatitis B surface antigen loss in chronic hepatitis B patients in Japan

2024-5-15